Direct medical cost and medications for patient of diabetes retinopathy in Beijing, China, 2016–2018
Authors' conclusion
Patients with retinopathy were associated with more complications. Compared with patients without retinopathy, the number of medications and total medical costs were significantly increased. From 2016 to 2018, there was an increase in the number of medication treatments for patients with retinopathy, but a decrease in cost.
Study context
- Population
- Diabetic patients with outpatient records in Beijing medical insurance, 2016–2018
- Participants
- 2,853,036 patients
- Exposure
- Diabetic patients with vs without retinopathy; 2018 vs 2016 in retinopathy patients
- Outcome
- Annual total drug cost
Methodological detailsBeijing medical insurance outpatient records
- Beijing medical insurance outpatient records
Main finding
As reported in the abstract
P < 0.0001
- Diagnosed with retinopathy
- 4.19 %-4.67 %
Observational data: associations, not effects.
Further findings
| Outcome | Retinopathy | Without retinopathy | P value |
|---|---|---|---|
| Number of diabetic complicationsMore with retinopathy | 1.65 ± 0.71 | 0.18 ± 0.44 | P < 0.0001 |
| Number of drugs usedMore with retinopathy | 5.11 ± 2.60 | 3.85 ± 2.34 | P < 0.0001 |
| Number of medications, retinopathy patients · 2018 vs 2016Increased in 2018 | P < 0.0001 | ||
| Annual total drug cost, retinopathy patients · 2018 vs 2016Decreased in 2018 | P < 0.0001 |
- Number of medications, retinopathy patients: 2018 5.11 ± 2.60
- Number of medications, retinopathy patients: 2016 4.95 ± 2.57
- Annual total drug cost, retinopathy patients: 2018 13,836 ± 11,244 ¥
- Annual total drug cost, retinopathy patients: 2016 15,642 ± 13,344 ¥
Original publication
Direct medical cost and medications for patient of diabetes retinopathy in Beijing, China, 2016–2018. Diabetes Res Clin Pract. Published 22 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →